M

Mendez Center For Clinical Research | Woodbridge, VA

Research site
(Unclaimed)
Location
13000 Harbor Center Drive, Suite 250, Woodbridge, Virginia, United States of America

Site insights

Top conditions

Top treatments

KT-301
Dapagliflozin
Finerenone
Lorundrostat

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

4 of 5 total trials

A Trial to Learn How Well Finerenone Works and How Safe it is in Adult Participants With Non-diabetic Chronic Kidney Disease (FIND-CKD)

Researchers are looking for a better way to treat people who have non-diabetic chronic kidney disease (non-diabetic CKD). The trial treatment, finere...

Active, not recruiting
Non-diabetic Chronic Kidney Disease
Drug: Finerenone (BAY94-8862)
Drug: Placebo

The aim of this Phase 2 study is to evaluate the safety and efficacy of the live biotherapeutic product, KT-301 (formerly US-APR2020), in the managem...

Enrolling
Chronic Kidney Disease stage4
Drug: Placebo
Drug: US-APR2020

This is a 2-part study evaluating the efficacy and safety of lorundrostat (an aldosterone synthase inhibitor \[ASI\]) for the treatment of hypertensi...

Enrolling
Chronic Kidney Disease
Drug: Part A - Lorundrostat QD + Dapaglifozin QD
Drug: Part A - Lorundrostat QD

This is an Open-Label Rollover Extension Clinical Trial to Evaluate the Long-Term Safety and Efficacy of KT-301 (formerly US-APR2020) in Subjects Wit...

Enrolling
Chronic Kidney Disease stage4
Drug: KT-301 (formerly US-APR2020)

Trial sponsors

K
Bayer logo
C
M

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems